The Federal Trade Commission (FTC) and several US states have accused Martin Shkreli of violating a lifetime restraining ...
Roche has added to its weight-loss drug pipeline again, turning to China's Rona Therapeutics for an RNAi candidate targeting ...
From patient engagement apps to clinical trial management platforms, development teams are increasingly turning to AI coding ...
Aspen Neuroscience, which is developing stem cell therapies for Parkinson's disease, has filed an IPO to raise additional ...
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Robbie Tyrie, founder and managing director of Torridon ...
A phase 2/3 trial of BioNTech's immunotherapy for head and neck cancer, BNT113, has failed to meet its objective, but the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results